The combination of VEGF-mediated immunomodulatory effects and chemotherapy-induced tumour cell antigen exposure may have a good synergistic anticancer effect (Ettinger et al. 2019; Reck et al. 2020). This evidence concerns the gene VEGFA and neoplasm.